CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer-Reference-Cited by-同舟云学术

CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer

Published:2021-11 Issue: Volume:Volume 14 Page:8689-8710
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Fan Xin^ORCID,Song Jianxiong,Fan Yating,Li Jiaqi,Chen Yutao,Zhu Huanhuan,Zhang Zhiyuan

Publisher

Informa UK Limited

Subject

General Medicine

Reference63 articles.

1. Oesophageal cancer

2. Zhang W, Wang P, Pang Q. Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review. Annals of Translational Medicine. 2020;8(18):1193–1193.

3. Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surgery today. 2020;50(1):12–20.

4. Current Status and Future Prospects for Esophageal Cancer Treatment

5. Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construct a prognostic model based on fatty acid metabolism/ferroptosis-related genes and reveal the immune heterogeneity and somatic mutation specificity of rectal adenocarcinoma in different groups;2023-11-25

2. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma;Molecular Biology Reports;2023-08-20

3. Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma;Stem Cells International;2023-04-30

4. Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma;Frontiers in Immunology;2023-01-25

5. Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma;Frontiers in Oncology;2022-12-15